Desai, Archita P. http://orcid.org/0000-0001-8731-2370
Gandhi, Devika
Xu, Chenjia
Ghabril, Marwan
Nephew, Lauren
Patidar, Kavish R.
Campbell, Noll L.
Chalasani, Naga
Boustani, Malaz
Orman, Eric S.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK123408, K23DK109202)
Article History
Received: 1 July 2022
Accepted: 14 December 2022
First Online: 19 December 2022
Declarations
:
: The authors declare that they have no conflict of interests which are directly relevant to this work. For full disclosure, relationships unrelated to this work are listed. Dr. Naga Chalasani served as a paid consultant to Abbvie, Madrigal, Zydus, Galectin, Boehringer-Ingelheim, Lilly, and Altimmune. He has research funding from NIH, Galectin, DSM, and Exact Sciences. Dr. Chalasani has equity in RestUp, Inc, a start-up specializing in health care staff placement. Dr. Boustani receives consulting fees and honoria from Lilly, Eisa, BioGen, Genetech, ACADIA, Merck. Additionally, he has patents pending for the “ABC Took Kit” and Agile Processes and has stock options in PPHM, RestUP and BlueAgillis.Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Indiana University Institutional Review Board. (Last Date of Approval July 20, 2022/No 1402496491).
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human research participants provided informed consent for publication of their data.